Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05LQD
|
|||
Former ID |
DNC006331
|
|||
Drug Name |
3-hydroxy-4,10-dimethyl-6H-benzo[c]chromen-6-one
|
|||
Synonyms |
CHEMBL205988; 3-hydroxy-4,10-dimethyl-6H-benzo[c]chromen-6-one; SCHEMBL6828383
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H12O3
|
|||
Canonical SMILES |
CC1=C2C3=C(C(=C(C=C3)O)C)OC(=O)C2=CC=C1
|
|||
InChI |
1S/C15H12O3/c1-8-4-3-5-11-13(8)10-6-7-12(16)9(2)14(10)18-15(11)17/h3-7,16H,1-2H3
|
|||
InChIKey |
PSZUCXJKMVSZSN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Estrogen receptor beta (ESR2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Estrogen signaling pathway | |||
Prolactin signaling pathway | ||||
Pathway Interaction Database | Plasma membrane estrogen receptor signaling | |||
Validated nuclear estrogen receptor beta network | ||||
Validated nuclear estrogen receptor alpha network | ||||
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Ovarian Infertility Genes | ||||
Integrated Pancreatic Cancer Pathway | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1468-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.